Lansoprazole

Phase 3Completed

0 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Heartburn

Conditions

Heartburn

Trial Timeline

Jun 1, 2006 → Jan 1, 2007

NCT ID

NCT00390390

About Lansoprazole

Lansoprazole is a phase 3 stage product being developed by Novartis for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT00390390. Target conditions include Heartburn.

What happened to similar drugs?

7 of 14 similar drugs in Heartburn were approved

Approved (7) Terminated (0) Active (7)

✅esomeprazole 40 mgAstraZenecaApproved

✅Esomeprazole magnesium (Nexium)AstraZenecaApproved

✅Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved

✅Esomeprazole Magnesium + LansoprazoleAstraZenecaApproved

✅Esomeprazole 20 mg + PlaceboPfizerApproved

✅Talcid (Hydrotalcite, BAY4516H) + Famotidine + PlaceboBayerApproved

✅Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mgBayerApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00390390	Phase 3	Completed	Jun 1, 2006	Jan 1, 2007	Heartburn

Competing Products

20 competing products in Heartburn

See all competitors

Product	Company	Stage	Hype Score
rabeprazole sodium	Eisai	Phase 3	40
rabeprazole sodium + placebo	Eisai	Phase 3	40
Rabeprazole sodium	Eisai	Pre-clinical	26
famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with water	Johnson & Johnson	Phase 1	29
esomeprazole 40 mg	AstraZeneca	Approved	43
Esomeprazole magnesium (Nexium)	AstraZeneca	Approved	43
Esomeprazole	AstraZeneca	Phase 3	40
Esomeprazole	AstraZeneca	Phase 3	40
Esomeprazole + Lansoprazole + Pantoprazole	AstraZeneca	Approved	43
Esomeprazole Magnesium + Lansoprazole	AstraZeneca	Approved	43
Famotidine FCT + Famotidine CT	Merck	Phase 1	29
Lanzoprazole	Novartis	Phase 3	40
Lansoprazole + Lansoprazole + placebo	Novartis	Phase 3	40
Tegaserod	Novartis	Phase 3	40
Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg + Lansoprazole + Calcium carbonate/magnesium hydroxide + Placebo	Novartis	Phase 2	35
Esomeprazole 20 mg + Placebo	Pfizer	Approved	43
bi-layer calcium carbonate tablet (BAY1180654) + Immediate release calcium carbonate tablet (BAY1180654)	Bayer	Phase 1	26
omeprazole/sodium bicarbonate + omeprazole magnesium	Bayer	Phase 1	26
Talcid (Hydrotalcite, BAY4516H) + Famotidine + Placebo	Bayer	Approved	40
Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mg	Bayer	Approved	40